𝔖 Bobbio Scriptorium
✦   LIBER   ✦

No evidence of somatic FGFR3 mutation in various types of carcinoma

✍ Scribed by Karoui, Mehdi; Hofmann-Radvanyi, Hélène; Zimmermann, Ute; Couvelard, Anne; Degott, Claude; Faridoni-Laurens, Laetitia; Ahomadegbe, Jean-Charles; Gazzeri, Sylvie; Brambilla, Elisabeth; Clerici, Thierry

Book ID
110065904
Publisher
Nature Publishing Group
Year
2001
Tongue
English
Weight
158 KB
Volume
20
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

No mutations of FGFR3 in normal urotheli
No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer
✍ Wolfgang Otto; Stefan Denzinger; Simone Bertz; Andreas Gaumann; Peter J. Wild; A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 94 KB

## Abstract Mutations in the fibroblast growth factor receptor 3 (__FGFR3__) gene causing constitutive oncogenic protein activation have been shown to be frequent in papillary noninvasive bladder tumours and are associated with a low risk of progression and a favourable outcome. __FGFR3__ alteratio

Constitutive activating mutation of the
Constitutive activating mutation of the FGFR3b in oral squamous cell carcinomas
✍ Yan Zhang; Yoshiko Hiraishi; Hua Wang; Ken-saku Sumi; Yasutaka Hayashido; Shigea 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 200 KB

A G to T mutation at nucleotide position 2128 in the human FGFR3b coding region resulting in a Cys for Gly substitution (G697C) in the tyrosine kinase domain was observed in 62% (44/71) of oral squamous cell carcinomas (OSCC) examined. Immunostained FGFR3b was found in the cytoplasm of prickle cells